Stereotaxis, Inc. (STXS): Volume dana dhuwit perusahaan

Simbol resmi perusahaan Stereotaxis Corp (STXS)

The implementation of sustainable production standards positively impacts the cash balance, whose historical trend on the GURU.Markets chart confirms stability. 0.00 indicates the current liquidity level. The financial base of Stereotaxis, Inc. (STXS) relies on stable service contracts and the low cyclicality of cardiac surgery. Business growth is driven by innovative Genesis systems, where AI manipulators provide precision control of catheters.

Dana dhuwit perusahaan: Stereotaxis Corporation (STXS) kanggo 04.07.2022 - 21.11.2026

Ringkesan rincian data analitis Stereotaxis Inc (STXS)

Analisis wiwitan perusahaan:Stereotaxis Corporation STXS
Produk merek Stereotaxis

This indicator measures the volume of liquid assets, determining the issuer's ability to cover short-term liabilities without selling fixed assets. For Stereotaxis, Inc. (STXS), with its narrow specialization in robotic cardiac surgery, a sufficient cash reserve is critical for maintaining costly IT developments. By analyzing the company's cash dynamics, an investor assesses the business's resilience to limited sales risks. A stable liquidity level confirms solvency, minimizing the probability of capital degradation.

Analisis perusahaan pesaing

Volume dana dhuwit perusahaan BSX|Dana dhuwit perusahaan EW (Edwards Lifesciences Corporation)|Dana dhuwit perusahaan ResMed RMD|Volume dana dhuwit perusahaan Insulet Corp PODD|ZBH: Dhuwit awis perusahaan|Sisa dhuwit perusahaan COO (CooperVision)|ALGN (Align Technology, Inc.) - Dhuwit awis perusahaan|Globus Medical, Inc. - Sisa dhuwit perusahaan|TMDX (TransMedics Group Inc) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alphatec Holdings ATEC|Dana dhuwit perusahaan CryoLife (AORT)|Enovis Corporation (ENOV) - Posisi dhuwit perusahaan|Integra LifeSciences Inc. - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Establishment Labs ESTA|Beta Bionics, Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan IRADIMED Corp IRMD|Embecta (EMBC) - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan TNDM (Tandem Corp)|Dana dhuwit perusahaan axogeninc.com|Dhuwit awis perusahaan SI-BONE, Inc. (SIBN)|Volume dana dhuwit perusahaan OFIX|Bioventus Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan orthopediatrics.com KIDS|TMCI: Dhuwit awis lan setara dhuwit awis perusahaan|SRTA: Dhuwit awis perusahaan|Carlsmed Inc - Gunggung dana dhuwit perusahaan|RxSight (RXST) - Dana dhuwit perusahaan|Dhuwit awis perusahaan ClearPoint|STIM (neurostar.com) - Volume dana dhuwit perusahaan|Sight Sciences, Inc (SGHT) - Aset likuid perusahaan|Volume dana dhuwit perusahaan OBIO|Aset likuid perusahaan Anika Therapeutics Inc.|Dana dhuwit perusahaan InspireMD, Inc. NSPR|Sisa dhuwit perusahaan ZJYL|VANI - Dana dhuwit perusahaan|Xtant Medical Holdings, Inc. - Gunggung dana dhuwit perusahaan|NeuroOne (NMTC) - Dana dhuwit perusahaan|Modular Med (MODD) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Myomo, Inc|Dhuwit awis perusahaan Envoy Medical (COCH)|Volume dana dhuwit perusahaan VVOS|NVNO (enVVeno Corp) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SINT (Sintx Technologies)|TNON: Dhuwit awis lan setara dhuwit awis perusahaan|Lifeward - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan AMIX (Autonomix Medical)|IVF: Volume dana dhuwit perusahaan|Posisi dhuwit perusahaan Bone Biologics Corporation BBLG|Dhuwit awis perusahaan AXNX|BIOLASE, Inc. (BIOL) - Aset likuid perusahaan|Volume dana dhuwit perusahaan DYNT|Aset likuid perusahaan Paragon 28|Volume dana dhuwit perusahaan INVO (INVO Bioscience, Inc.)